ESG

Systecon's new Opus Suite+ integrates AI and cloud tech, unifying its core tools to optimize readiness for the F-35, GCAP, and critical industries.

With promising early data and a unique brain delivery method, AviadoBio's AVB-101 trial offers new hope for patients with FTD-GRN, a devastating disease.

Materialise is transferring its RapidFit tooling business to its management, sharpening its focus on medical and software to boost long-term growth.

The neurotech pioneer reports strong sales for its spinal cord injury therapy, secures key FDA approvals, and plans for major US stock market entry.

A new, highly selective oral drug for the most common form of dwarfism has been cleared for U.S. trials, offering hope for a more convenient treatment.

A shocking new installation reveals a dangerous blind spot: your car isn't protecting you from the sun's harmful rays. Here's what you need to know.

After a successful shift to a royalty model, the firm reports stronger financials and confirms it is weighing a merger or acquisition.

Jeffrey Hollender's new book reveals the untold story of building a green empire, the pain of being fired, and the fight to keep a mission alive.

A new book details a Korean Zen master's dialogues with an AI, using ancient meditation to explore machine consciousness. Is this a spiritual breakthrough?

A massive on-premises data archive goes live for a major government agency, leveraging a zero-downtime design to secure the nation's critical digital memory.

With improved financials and progress on therapies for cannabis use disorder and Down syndrome, the French biotech charts a confident course for the future.

The new DSP leverages 100% first-party HCP data, script-lift measurement, and sustainability metrics to offer unparalleled precision and performance.

Agena Bioscience's new test helps labs align with updated ACMG recommendations for cystic fibrosis, aiming for more equitable and efficient carrier screening.

With backing from CPG giants, the creatine gummy maker plans to use its new $20M funding to make the supplement a daily wellness staple for everyone.

A new 73-bed facility in Newark will create 122 jobs, expand services for an aging population, and set a new standard for rehabilitation in the region.

Christine Cooper's appointment to the SIIA board places a fierce cost-containment advocate at the heart of policy-making for self-insured health plans.

New research shows government digital services are widely available but rarely used, as legacy systems and low adoption create an invisible barrier to efficiency.

A new AI test promises to tell patients their personal benefit from chemotherapy, aiming to end decades of one-size-fits-all treatment decisions.

Soaring diesel prices are pushing Canada's truckers to the brink, threatening a fragile recovery and signaling higher costs for consumers on everything.

New research shows parents welcome corporate sponsors in schools to fill funding gaps, creating a powerful new marketing channel built on community trust.